Opus Medical

About

Breathe Well, incubated at the University of Sydney, develops patient-breathing assistance technology to standardize respiratory motion during radiotherapy delivery for cancer patients.

Mission

Breathe Well is a startup incubated at Sydney University that has developed technology to help cancer patients breathe predictably during a course of radiotherapy. The effort is led by Professor Paul Keall and his team. The technology is intended to assist patient breathing to improve radiotherapy delivery. The article does not provide technical specifications, commercialization status, or operating metrics. It notes that Sydney Seed Fund has invested in the company. Amounts, instruments, and other financial terms were not disclosed. No future plans were described in the article.

Quick Facts